Total planned funding: $70,914,507
Allocations
Countries/Regions
Burundi | $70,914,507 |
Organizational Types
NGO | $30,898,696 |
Private Contractor | $19,214,352 |
Unknown | $8,948,469 |
Own Agency | $6,711,681 |
University | $4,921,309 |
Other USG Agency | $220,000 |
Program Areas
Treatment | $20,547,028 |
Prevention | $13,480,815 |
Governance and Systems | $13,448,834 |
Testing | $10,056,222 |
Care | $8,875,609 |
Management and Operations | $4,505,999 |
Budget Codes
HTXS: Treatment: Adult Treatment | $12,698,179 |
HVCT: Testing: HIV Testing and Counseling | $10,056,222 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,736,217 |
OHSS: Health Systems Strengthening | $6,796,395 |
HTXD: Treatment: ARV Drugs | $5,896,736 |
HKID: Care: Orphans and Vulnerable Children | $4,713,475 |
HVMS: Management and Operations | $4,505,999 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,358,086 |
HVSI: Strategic Information | $3,723,598 |
HLAB: Laboratory Infrastructure | $2,928,841 |
HBHC: Care: Adult Care and Support | $2,287,686 |
PDTX: Treatment: Pediatric Treatment | $1,952,113 |
PDCS: Care: Pediatric Care and Support | $968,061 |
HVTB: Care: TB/HIV | $906,387 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $386,512 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
Top Partner Programs
FHI 360:
$27,366,803
Countries/Regions
Chemonics International:
$10,604,386
Countries/Regions
Not Available:
$6,945,566
Countries/Regions
USG Aggregated Agencies:
$4,245,202
Countries/Regions